Yazar "Demir, Suleyman" seçeneğine göre listele

Listeleniyor 1 - 3 / 3
  • Küçük Resim Yok
    Öğe
    Analysis of manganese superoxide dismutase (MnSOD: Ala-9Val) and glutathione peroxidase (GSH-Px: Pro 197 Leu) gene polymorphisms in mood disorders
    (Assoc Basic Medical Sci Federation Bosnia & Herzegovina Sarajevo, 2013) Cumurcu, Birgul Elbozan; Ozyurt, Huseyin; Ates, Omer; Gul, Isil Gogcegoz; Demir, Suleyman; Karlidag, Rifat
    We investigated the etiopathogenetic role of manganese superoxide dismutase (MnSOD) (Ala-9Val) and glutathione peroxidase (GSH-Px) (Pro 197 Leu) gene polymorphisms in patients diagnosed with major depressive disorder (MDD) and bipolar I disorder (BD). Eighty patients with MDD, 82 patfents with BD (total 162 patients) and 96 healthy controls were enrolled in this study and genotyped using a Real Time-Quantitative Polymer Chain Reaction (RT-qPCR)-based method. The patients with BD and MDD and the controls had a similar distribution of the genotypes and alleles in the Ala-9Val MnSOD gene polymorphism. Comparison of the MDD group and control group regarding the Pro 197 Leu GSH-Px gene polymorphism revealed similar genotype distribution but different allele distribution. The BD group and control group were similar both for genotypes and for alleles when compared regarding the Pro 197 Leu GSH-Px gene polymorphism. The combined analysis (MDD plus BD) also failed to find any association between the Ala-9Val MnSOD and Pro 197 Leu GSH-Px gene polymorphism. Although small statistical power of the current study the significant difference between patients with depression and the control group for the Pro 197 Leu GSH-Px polymorphism indicates that the distribution of these alleles may have a contribution in the physiopathogenesis of depression. One of the limitation of the current study is that the sample size is too small. Understanding of the exact role of Pro 197 Leu GSH-Px polymorphism in the development of depression needs to further studies with more sample size and high statistical power. (C) 2013 Association of Basic Medical Sciences of FB&H. All rights reserved
  • Küçük Resim Yok
    Öğe
    Total antioxidant capacity and total oxidant status in patients with major depression: Impact of antidepressant treatment
    (Wiley, 2009) Cumurcu, Birgul Elbozan; Ozyurt, Huseyin; Etikan, Ilker; Demir, Suleyman; Karlidag, Rifat
    Aim: The purpose of the present study was to investigate whether total antioxidant capacity (TAC) and total oxidant status (TOS) are associated with major depressive disorder (MDD) and to evaluate the impact of antidepressant treatment on TAC and TOS in MDD. Methods: Fifty-seven MDD patients and 40 healthy controls participated in the study. Serum TAC and TOS were measured both in patients and controls using Erel's methods. Patients were treated with antidepressant drugs for 12 weeks. The treatment course was evaluated using the Montgomery-Asberg Depression Rating Scale (MADRS) in all patients. Results: TOS and oxidative stress index (OSI) were higher (P = 0.0001 for both) and TAC was lower (P = 0.0001) in the MDD group compared with those of the controls. After 3 months of antidepressant treatment, TOS and OSI were decreased and TAC was increased compared with the pretreatment values (P = 0.0001, for all). Furthermore, there were significant positive correlations between the severity of the disease and serum TOS and OSI (r = 0.584, P = 0.0001; r = 0.636, P = 0.0001, respectively). A negative correlation was found between the severity of the disease and serum TAC (r = -0.553, P = 0.0001) at the pre-treatment stage. Conclusion: Treatment administered for 3 months to MDD patients increases TAC while decreasing TOS and OSI.
  • Küçük Resim Yok
    Öğe
    Use of a Biopolymer for Road Pavement Subgrade
    (Mdpi, 2023) Cabalar, Ali Firat; Akbulut, Nurullah; Demir, Suleyman; Yildiz, Ozgur
    This paper presents an extensive series of laboratory works and a prediction model on the design of a road pavement subgrade with Xanthan Gum (XG) biopolymer. The experimental works were carried out using mixtures of conventional aggregate for road pavement construction and XG at the ratios of 0%, 1%, 2%, and 5%, by dry weight. Unconfined compressive strength (UCS) and California bearing ratio (CBR) tests were conducted during the experimental works at the end of the various curing periods (4, 8, 16, and 32 days). An example of an improvement in the UCS values for a specimen with 5% XG addition tested at the end of 4-daycuring yields about a 200% increment by the end of a 32-daycuring. The CBR values of clean aggregates were found to be increased by about 300% by 5% XG addition for all curing periods applied. Furthermore, the energy absorption capacity of the aggregates was observed to be increased significantly by both XG inclusion and curing period. Moreover, scaled conjugate gradient (SCG) training algorithm-based models developed for the prediction of CBR and UCS test results displayed a very high estimation performance with the regression coefficients of R-2 = 0.967 and R-2 = 0.987, respectively. Evidently, XG biopolymer is provably of use as an alternative inclusion in road pavement subgrades constructed with conventional aggregates.